These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8757020)

  • 41. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.
    Nestor PJ; Caine D; Fryer TD; Clarke J; Hodges JR
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1521-9. PubMed ID: 14617709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
    Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.
    Kazemifar S; Manning KY; Rajakumar N; Gómez FA; Soddu A; Borrie MJ; Menon RS; Bartha R;
    PLoS One; 2017; 12(6):e0178529. PubMed ID: 28582450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease.
    Mentis MJ; Weinstein EA; Horwitz B; McIntosh AR; Pietrini P; Alexander GE; Furey M; Murphy DG
    Biol Psychiatry; 1995 Oct; 38(7):438-49. PubMed ID: 8672604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain [18F]FDDNP binding and glucose metabolism in advanced elderly healthy subjects and Alzheimer's disease patients.
    Tauber C; Beaufils E; Hommet C; Ribeiro MJ; Vercouillie J; Vierron E; Mondon K; Cottier JP; Gissot V; Guilloteau D; Camus V
    J Alzheimers Dis; 2013; 36(2):311-20. PubMed ID: 23609763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease.
    Bailly M; Ribeiro MJ; Vercouillie J; Hommet C; Gissot V; Camus V; Guilloteau D
    Clin Nucl Med; 2015 Feb; 40(2):e111-6. PubMed ID: 25549345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
    Mosconi L; Andrews RD; Matthews DC
    J Alzheimers Dis; 2013; 35(3):509-24. PubMed ID: 23478305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study.
    Babiloni C; Del Percio C; Caroli A; Salvatore E; Nicolai E; Marzano N; Lizio R; Cavedo E; Landau S; Chen K; Jagust W; Reiman E; Tedeschi G; Montella P; De Stefano M; Gesualdo L; Frisoni GB; Soricelli A
    Neurobiol Aging; 2016 Dec; 48():122-134. PubMed ID: 27668356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.
    Meltzer CC; Leal JP; Mayberg HS; Wagner HN; Frost JJ
    J Comput Assist Tomogr; 1990; 14(4):561-70. PubMed ID: 2370355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neural correlates of the Clock Drawing Test performance in Alzheimer's disease: a FDG-PET study.
    Lee DY; Seo EH; Choo IH; Kim SG; Lee JS; Lee DS; Jhoo JH; Kim KW; Youn JC; Woo JI
    Dement Geriatr Cogn Disord; 2008; 26(4):306-13. PubMed ID: 18841015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.